Testicular Cancer clinical trials in Virginia

5 actively recruiting testicular cancer trials at 8 sites across Virginia.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Network

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it dev…

Sponsor: Children's Oncology Group

NCT ID: NCT03067181

Sites in Virginia:

University of Virginia Cancer Center — Charlottesville, Virginia
Children's Hospital of The King's Daughters — Norfolk, Virginia
Naval Medical Center - Portsmouth — Portsmouth, Virginia
VCU Massey Comprehensive Cancer Center — Richmond, Virginia
Carilion Children's — Roanoke, Virginia

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy and immunotherapy (chemo-immunotherapy) for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. Inotuzumab o…

Sponsor: Children's Oncology Group

NCT ID: NCT03959085

Sites in Virginia:

University of Virginia Cancer Center — Charlottesville, Virginia
Inova Fairfax Hospital — Falls Church, Virginia
Children's Hospital of The King's Daughters — Norfolk, Virginia
Naval Medical Center - Portsmouth — Portsmouth, Virginia
VCU Massey Comprehensive Cancer Center — Richmond, Virginia

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

The primary purpose of this study is to determine whether the investigational drug XmAb541 is safe and well tolerated, and to determine an optimal and safe dose(s) for further study. The study will also evaluate the effect of XmAb541 on tu…

Sponsor: Xencor, Inc.

NCT ID: NCT06276491

Sites in Virginia:

University of Virginia — Charlottesville, Virginia

View on ClinicalTrials.gov →

NA Recruiting Network

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

Sponsor: Eastern Cooperative Oncology Group

NCT ID: NCT05108298

Sites in Virginia:

Wellmont Medical Associates-Bristol — Bristol, Virginia
Southwest VA Regional Cancer Center — Norton, Virginia

View on ClinicalTrials.gov →

Recruiting Industry

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…

Sponsor: Massive Bio, Inc.

NCT ID: NCT03452774

Sites in Virginia:

Massive Bio SYNERGY-AI site — Charlottesville, Virginia

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20